von Tobias Borgers | Okt. 8, 2019 | Bayer
The FDA has approved Novartis’s new eye drug brolucizumab for wet age-related macular degeneration, which will match Bayer’s rival Eylea on price per dose but reduce costs with a less frequent dosing regimen.Novartis’ Beovu (brolucizumab) has matched the performance...
von Tobias Borgers | Okt. 8, 2019 | Boehringer
An extensive analysis of the Global Aerosol Therapy market strategy of the leading companies in the precision of import/export consumption, supply and demand figures, cost, price, revenue and gross margins. The report starts by an introduction about the company...
von Tobias Borgers | Okt. 7, 2019 | Abbvie
Market Deeper released a new market study on Global Sevoflurane Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report...
von Tobias Borgers | Okt. 7, 2019 | Boehringer
The Global Adalimumab Biosimilar report offers a summary of a substantial number of statistics in the Global Adalimumab Biosimilar . Data collected in the report highlights the current market trends. Also, it provides the users with the detailed statistics of the...
von Tobias Borgers | Okt. 4, 2019 | Driam
PersonalmeldungenIn Leverkusen und Karlstadt gibt es Änderungen auf Führungspositionen. Covestro stellt eine neue Produktionsleiterin vor, Düker verabschiedet einen Geschäftsführer. PROCESS fasst die Personalmeldungen der Woche zusammen. Firmen zum Thema Einen Wechsel...
